🟢 95/100

This product looks safe

  • Kaff2 Citrate: 400mg is 1.1× the Tolerable Upper Intake Level (350mg)
  • 50% of ingredients have research evidence
C Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

⚠️ Kaff2 Citrate: 400mg is 1.1× the Tolerable Upper Intake Level (350mg)

Label Data

6.1 Gram(s) Serving Size
30 Servings
Other Combinations Product Type
50% Evidence Coverage

Supplement Facts — Evidence Check

Sodium
240 mg (10% DV)
1.5 Gram(s)
📊 Market median: 125.0mg (294 products) 📚 36 studies (Tier A: 1, B: 7)
RDA 550mg This product: 1.5mg UL 3500mg
📊 Market median: 500.0mg (223 products) 📚 22 studies (Tier A: 0, B: 1)
This product: 750mg
📊 Market median: 4002.0mg (1 products) 📚 20 studies (Tier A: 0, B: 2)
This product: 500mg
400 mg
⚠️ Exceeds Tolerable Upper Intake Level by 1.1× (UL: 350 mg)
RDA 420mg This product: 400mg UL 350mg
📊 Market median: 496.0mg (192 products) 📚 20 studies — no high-quality reviews
This product: 300mg
📊 Market median: 180.0mg (239 products) 📚 43 studies (Tier A: 1, B: 19)
This product: 200mg UL 400mg
Rauwolscine
2 mg

Other Ingredients

Natural and Artificial flavor Citric Acid Malic Acid Sodium Bicarbonate Trisodium Citrate Sucralose Silica Calcium Silicate Acesulfame Potassium

Label Claims — Verification

All Other
Structure/Function
All Other (97% of products) Structure/Function (90% of products) Nutrient (42% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Recommended Use: Shake container before each use. Mix 1 scoop into 8-10 oz of cold water 30-45 minutes before working out. Use only 1 serving (1 scoop) in a 24 hour period. Never take more than 1 scoop.

⚠️ Warnings & Precautions

Warning: Important Must Read: Not to be used by anyone under the age of 18.

Do not use if pregnant or nursing, currently taking PDE5 inhibitors or other nitrates for chest pain.

Never exceed the recommended maximum dosage.

Do not consume synephrine, yohimbe, caffeine, thyroid-boosting compounds from other sources, including but not limited to coffee, tea, soda, energy drinks and other dietary supplements or medications containing phenylephrine, caffeine, or any stimulants whatsoever.

This product contains caffeine. Do not use product for longer than 4 weeks and make sure that usage is followed by a 2-week-off-period.

Consult your physician prior to use if you are taking any medication, including but not limited to MAO inhibitors, anti-depressants, asprin, non-steroidal anti-inflammatory drugs or products containing phenylephrine, ephedrine, pseudeophedrine, phenylethylamine or other stimulants.

Consult your physician prior to use if you have a medical condition, including but not limited to heart, liver, kidney or thyroid disease, psychiatric disorders, difficulty urinating, diabetes, high blood pressure, pernicious anemia, cardiac arrhythmia, hyper beta-alaninemia, recurrent headaches, enlarged prostate or glaucoma. Discontinue use 2 weeks prior to surgery. Immediately discontinue if you experience rapid heartbeat, dizziness, severe headaches or shortness of breath. This product contains ingredients that may be banned by some sports organizations.

Do not use if outer safety seal is broken.

Keep out of reach of children.

Allergen Warning: Manufactured on equipment that processes products containing milk, egg, soybean, fin fish and wheat.

Never take more than 1 scoop.

🧪 Formulation Notes

This product contains caffeine.

Additional Information

As individuals vary so may results from using this product.

Store out of sunlight in a cool, dry place.

Store in a cool, dry place (60(0)F to 80(0)F).

30 servings Extreme stimulant energy Explosive performance pre-workout

Natural & artificial flavors

LBL-OUTLIFTCONC-BL-6.5OZ-V1-US

Product Details

UPC / SKU 8 57839 00686 0
DSLD Entry Date 2018-04-25
Product Type Other Combinations
Form Powder
DSLD ID 176370
Data Updated 2026-04-11

Research Evidence

28 Research Sources
47 Avg Quality Score
11 Clinical Trial
8 Rct
2 Guideline
2 Meta Analysis
2 Regulatory Source
1 Systematic Review
1 Openfda Safety
B Greater Choline-Containing Compounds and Myo-inositol in Treatment-Resistant Versus Responsive Schizophrenia: A 1H-Magnetic Resonance Spectroscopy Meta-analysis
Meta Analysis Biological psychiatry. Cognitive neuroscience and neuroimaging 2024
B Integrating multi-structure covalent docking with machine-learning consensus scoring enhances potency ranking of human acetylcholinesterase inhibitors.
Guideline Briefings in bioinformatics 2026
B Evidence-based clinical practice guidelines for functional dyspepsia 2021.
Guideline Journal of gastroenterology 2022
B Scientific Opinion on health claims related to choline
Regulatory Source EFSA Journal 2011
C Effectiveness of nutritional interventions to prevent nonprogressive congenital and perinatal brain injuries: a systematic review and meta-analysis of randomized trials
Meta Analysis Nutrition reviews 2022
C Two methods for assessment of choline status in a randomized crossover study with varying dietary choline intake in people: isotope dilution MS of plasma and in vivo single-voxel magnetic resonance spectroscopy of liver.
Rct The American journal of clinical nutrition
C Choline and betaine concentrations in plasma discriminate levels of dietary choline intake in healthy adults: analysis of a double-blind randomized crossover controlled feeding study.
Rct The American journal of clinical nutrition
C Nutrient-based therapies for bipolar disorder: a systematic review
Systematic Review Psychotherapy and psychosomatics 2013
C The association of betaine, homocysteine and related metabolites with cognitive function in Dutch elderly people
Rct The British journal of nutrition 2007
C Differential metabolism of choline supplements in adult volunteers.
Rct European journal of nutrition
View all evidence for Choline →

Compare Similar Products

View all Choline products →